Mechanistically, exposure to hOM-MSCs enhances neuroinflammatory response and neural functional recovery partially through TGF-β1-mediated activation of the ALK-PI3K-Akt signaling pathway in microglia within the SN of PD patients. This evidence concerns the gene AKT1 and Parkinson disease.